guanabenz has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knutelska, J; Kotańska, M; Mika, K; Nicosia, N; Szafarz, M | 1 |
| Iwasaki, Y; Kakizaki, S; Matsumoto, S; Mori, M; Ozawa, A; Satoh, T; Trejo, JAO; Uchiyama, Y; Yamada, E; Yamada, M; Yoshino, S | 1 |
2 other study(ies) available for guanabenz and Obesity
| Article | Year |
|---|---|
Guanabenz-an old drug with a potential to decrease obesity.
Topics: Animals; Body Weight; Guanabenz; Guanidines; Mice; Obesity; Pharmaceutical Preparations; Phenolsulfonphthalein; Rats | 2022 |
Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity.
Topics: Administration, Oral; Animals; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Repositioning; Gene Expression Regulation; Guanabenz; Hep G2 Cells; Humans; Lipogenesis; Mice; Non-alcoholic Fatty Liver Disease; Nuclear Proteins; Obesity; Receptors, Leptin | 2020 |